Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

NXTMH
Nexstim Plc – HEL
Weekly Share Price & Valuation Overview
Market Overview
Open
13.4500
Close
13.0500
High
13.4500
Low
12.6500
Trend
0.84092

Nexstim Plc

Finland • HEL - Nasdaq Helsinki • NXTMH • Currency: EUR

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provides Navigated Brain Stimulation (NBS) 5 system, a TMS system for the pre-surgical mapping of the motor cortex and the speech areas of the brain; and NBS 6 and NBT, a navigated brain therapy systems for the treatment of major depressive disorder and chronic neuropathic pain. The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. to develop, manufacture, and supply y Sinaptica's patented precision neuromodulation device based on the Nexstim NBS 6 medical TMS and neuronavigation systems and related software; and a development and distribution collaboration with Brainlab AG for the development of solutions for non-invasive mapping of specific parts of the brain and Brainlab's role as a distributor for certain Nexstim products. The company was incorporated in 2000 and is headquartered in Helsinki, Finland.

Key strengths
  • High gross margin (≥35%) suggests strong pricing power or cost control.
  • Revenue growth ≥10% indicates solid top-line momentum.
  • Quick ratio ≥1.0 indicates obligations can be met without inventory.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
Market Cap Total equity value of the company (share price × shares outstanding).
EUR 101.28M
Enterprise Value Operating value: market cap + total debt − cash.
EUR 105.34M
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
EUR 10.21M
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
EUR 8.38M
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
EUR -54.72K
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
EUR 1.49
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
-0.13
Shares Outstanding
7.18M
Float Shares
3.92M
Implied Shares Outstanding
7.18M
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
9.08%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-53.58%
Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
82.04%
Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-8.74%
ROA Return on assets: net income ÷ total assets.
-1.53%
ROE Return on equity: net income ÷ shareholder equity.
-27.30%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Strong Year-over-year revenue growth.
15.70%
Earnings Growth (YoY) Year-over-year earnings growth.
-55.30%
Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-51.50%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
1.26
Debt to Equity Total debt ÷ shareholder equity; leverage.
1.45
Total Cash Cash and equivalents.
EUR 3.86M
Total Debt Short + long-term interest-bearing debt.
EUR 5.36M
Net Debt Total debt − cash (negative = net cash).
EUR 1.50M
Debt / EBITDA Leverage relative to operating earnings; lower is safer.
-98.00
Cash Flow Shown only when internally consistent; margins are TTM.
Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
EUR 1.88M
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
EUR 630.82K
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
18.42%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
6.18%
Sharemaestro House View
Confidence: 1 Sharemaestro internal conviction (0–3, higher is better). Risk: 1 Sharemaestro internal risk profile (0–3, higher is safer). Operational: 2 Operational quality/consistency (0–3, higher is better). Composite Score: 1 Overall internal composite (0–3, higher is better). Suggested Allocation: 1.67% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading. 54.5%
Insiders Shares held by company insiders (officers, directors). 48.6%
Institutions Shares held by institutions (funds, pensions). 0.9%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
None detected
Net Debt Total debt − cash (negative = net cash).
EUR 1.50M
14.7% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 59
Methodology Notes
  • Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
  • Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-31 21:11

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.